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Biotin-dependent enzymes contain a biotinyl-lysine residue in a
conserved sequence motif, MKM, located in a surface hairpin
turn in one of the two b-sheets that make up the domain. A sub-
gene encoding the 82-residue C-terminal biotinyl domain from
the biotin carboxy carrier protein of acetyl-CoA carboxylase
from Escherichia coli as a fusion protein with glutathione S-
transferase was created and over-expressed in E. coli. The biotinyl
domain was readily released by cleavage with thrombin. Five
mutant domains were created in which the conserved MKM
motif was systematically replaced: by MAK and KAM, in which
the target lysine is moved one place ; by KKM and MKK, in
which a second potential site for biotinylation is introduced; and
by DKA, the motif found in the correspondingly conserved site
of lipoylation in the structurally related lipoyl domains of 2-oxo
acid dehydrogenase multienzyme complexes. No biotinylation of
the MAK or KAM mutants was observed in io or by purified
biotinyl protein ligase in itro ; in the KKM and MKK mutants,
INTRODUCTION
Biotin carboxy carrier protein (BCCP) is one of the three
functional subunits in the acetyl-CoA carboxylase of Escherichia
coli. This enzyme catalyses the biotin-dependent carboxylation
of acetyl-CoA to malonyl-CoA, the first committed step in the
biosynthesis of fatty acids [1]. BCCP is a homodimer [2], each
polypeptide chain containing 156 amino acid residues, as deduced
from the DNA sequence of the corresponding gene [3]. The
biotinyl group is attached post-translationally by the action of
a biotinyl protein ligase (BPL, also known as biotin holoenzyme
synthetase), which catalyses the formation of an amide linkage
between the carboxy group of the biotin and the N '-amino group
of a specific lysine residue in BCCP. The biotinyl-lysine (biocytin)
residue is located in the C-terminal region of the BCCP protein,
in an independently folded domain of about 80 amino acids
[4–6], the structure of which has been established independently
by means of X-ray crystallography [7] and, in solution, by means
of NMR spectroscopy (E. L. Roberts, R. W. Broadhurst, M. J.
Howard, A. Chapman-Smith, J. E. Cronan, J. C. Wallace and
R. N. Perham, unpublished work).
The structure of the biotinyl domain is that of a flattened b-
barrel, comprising two 4-stranded b-sheets, with the N- and C-
terminal residues close together in space in one sheet and the
biotinyl-lysine residue located in a highly conserved MKM
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only one lysine residue, presumed to be that in its native position
in the hairpin turn, was found to be biotinylated in io and in
itro. The DKA mutant was not biotinylated in io, but was
partly lipoylated and octanoylated. It was also a poor substrate
for lipoylation in itro catalysed by the E. coli lipoyl protein
ligase encoded by the lplA gene. The flanking sequence in the
MKM motif is important, but not crucial, and appears to have
been conserved in part to be compatible with the subsequent
carboxylation reactions of biotin-dependent enzymes. The DKA
motif, displayed in the hairpin loop, is sufficient to address
lipoylation in E. coli but probably by a pathway different from
that mediated by the lplA-dependent ligase. The recognition of
the structurally homologous lipoyl and biotinyl domains by the
appropriate ligase evidently has a major structural component to
it, notably the positioning of the target lysine residue in the
exposed hairpin loop, but there appear to be additional rec-
ognition sites elsewhere on the domains.
sequence in an exposed b-turn in the other sheet (Figure 1). The
biotinyl-lysine residue is thus well placed to act as a swinging arm
in the mechanism of acetyl-CoA carboxylase, becoming
carboxylated at the active site of the biotin carboxylase subunit
and passing on the carboxy group at the active site of the
carboxytransferase subunit. In E. coli, BCCP is the only
biotinylated protein, but a comparable domain with a similar
function in the catalytic mechanism is present in all biotin-
dependent enzymes [8,9]. As predicted previously and despite
minimal amino acid sequence similarity [10], the structure of the
biotinyl domain closely resembles that of the lipoyl domain in the
dihydrolipoyl acyltransferase component of 2-oxo acid dehydro-
genase multienzyme complexes [11,12]. The lipoyl domain also
consists of two 4-stranded b-sheets, with the lipoylated lysine
residue prominently displayed in a highly conserved DKA
sequence at the tip of the single b-turn in the b-sheet opposite the
N- and C-terminal residues [13–17]. In these enzymes too, the
modified (lipoylated) lysine residue functions as a swinging arm
ferrying substrate between the three active sites in the enzyme
complex.
In E. coli, BPL is encoded by the birA gene [18,19], which has
been sequenced [20]. The X-ray crystal structure of BPL, which
also acts as a repressor of the biotin operon, has been solved [21].
The catalytic mechanism of the enzyme involves a two-step
process : activation of the carboxy group of biotin by reaction
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Figure 1 Three-dimensional structure of the biotinyl domain from the
BCCP of E. coli acetyl-CoA carboxylase
The two 4-stranded b-sheets are indicated in dark and light-shading, and the MKM motif in the
hairpin loop housing the biotinyl-lysine residue (Lys-50) is indicated. The structure is taken from
the coordinates of Athappilly and Hendrickson [7] and the Figure was constructed using the
program MOLSCRIPT [7a].
with ATP to form biotin-5«-AMP and elimination of pyro-
phosphate, followed by transfer of the biotinyl group to the
target lysine residue of BCCP and release of AMP. The biotin-
5«-AMP, bound to BPL, acts as the co-repressor of the biotin
operon, which creates an elegant model for the regulation of
biotin biosynthesis [22].
A similar system exists for the post-translational modification
of lipoyl domains. In E. coli two genes (lplA and lipB) have been
postulated to encode independent pathways for the attachment
of the lipoyl group to the apo-protein [23]. The lplA gene has
been cloned and over-expressed [24] and the product, lipoyl
protein ligase (LPL), catalyses a reaction corresponding to that
of BPL, but with lipoyl-5«-AMP as the reaction intermediate. It
utilizes exogenous d-lipoic acid as its preferred substrate but can
use octanoic acid and l-lipoic acid [25], corresponding to the B
form of the enzyme described previously [26]. In contrast, the
product of the lipB gene relies on an endogenous source of lipoic
acid supplied by the lipA-dependent biosynthetic route [23] and
is likely to be responsible for most of the aberrant octanoylation
of lipoyl domains that occurs under conditions of lipoic acid
deficiency [27,28].
Two important questions present themselves in the light of the
above findings. How do the BPL and LPL enzymes distinguish
biotinyl and lipoyl apo-domains as substrates for biotinylation
and lipoylation, respectively? And how are the target lysine
residues in the biotinyl and lipoyl domains selected for post-
translational modification? We have shown previously that the
positioning of the target lysine residue at the tip of the b-turn in
the lipoyl domain, rather than the conserved DKA sequence in
which it is found, plays a dominant role in the targetting process
in io [29]. In this paper, we describe experiments in io and in
itro which demonstrate that placing the target lysine residue at
the tip of the b-turn in the biotinyl domain is likewise essential
for its post-translational modification by BPL and that the
highly conserved MKM sequence is of lesser importance.
Importing the DKA motif from the b-turn of the lipoyl domain
in place of the MKM motif in the biotinyl domain renders the
latter ineffective as a substrate for BPL but confers on it the
ability to become lipoylated, albeit poorly. The results throw new
light on the specificities of BPL and LPL and the pattern of
differing recognition signals displayed by lipoyl and biotinyl
domains to ensure correct post-translational modification, which
is essential to their biological activity.
MATERIALS AND METHODS
Materials
All chemicals used in the preparation of buffers and solutions
were of reagent grade. Bacteriological media were purchased
from Oxoid, Unipath Laboratories. E. coli host strain XL1-Blue
was from Stratagene. E. coli host strains BL21(DE3) and
BL21(DE3)plysS and the expression vector pET11c were from
Novagen. Plasmid pGEX-2T was purchased from Pharmacia
Biotech. dl-Lipoic acid, octanoic acid, d-biotin and PMSF were
purchased from Sigma, ATP was from Boehringer Mannheim,
and isopropyl 1-thio-b-galactopyranoside (IPTG) and dithio-
threitol (DTT) were from Melford Laboratories Ltd. Restriction
endonucleases and DNA-modifying enzymes were from
Pharmacia Biotech; Pfu DNA polymerase was purchased from
Stratagene Ltd. Oligonucleotide primers were synthesized by Mr.
M. Weldon in the Protein and Nucleic Acid Facility, Department
of Biochemistry, University of Cambridge, Cambridge, U.K.
DNA manipulations
Standard protocols for molecular biology were used as described
elsewhere [30]. DNA fragments were purified after agarose gel
electrophoresis using a Geneclean2 kit (BIO101). The Quiagen
plasmid kit and the WizardTM DNA purification kit from
Promega were used for plasmid isolation. Automated DNA
sequence analysis was carried out by Mr. J. Lester and Mrs.
K. Pennock (Department of Biochemistry, University of
Cambridge,Cambridge, U.K.) using the PrismTM Ready Reaction
DyeDeoxyTM Terminator and the Catalyst 800 Molecular Biology
Labstation, as described by the manufacturer (Applied Bio-
systems Inc.). Sequence data were analysed by the seqEd4
analysis software (Applied Biosystems Inc.). PCRs were carried
out under mineral oil in a volume of 100 ll. The reaction
mixtures contained 200 lM dNTPs, 2 mM MgCl
#
, 100 pmol
each of sense and anti-sense primers, DNA template (amount as
stated) and 2±5 units of Pfu DNA polymerase. PCR parameters
were: 5 min at 94 °C (1 cycle) ; 1 min at 94 °C, 1 min 30 s at
55 °C, 2 min at 72 °C (25 cycles) ; and 10 min at 72 °C (1 cycle).
Construction of the expression system for the biotinyl domaian
The region of the gene encoding the biotinyl domain of E. coli
BCCP was amplified by PCR using 250 ng of E. coli genomic
DNA as template and the oligonucleotides Dbccp and Rbccp as
primers. Dbccp, 5«-AGCGGATCCGCAGCGGAAATCAGT-
GGTCACATC, primes on the coding strand and contains a
BamHI cleavage site (underlined) ; Rbccp, 5«-GTTCGAATTC
TTACTCGATGACGACCAGCGGCTC, primes on the non-
coding strand and carries an EcoRI site (underlined) and a stop
codon (in bold). After digestion of the purified PCR product
with BamHI and EcoRI, the resulting 255 bp DNA fragment was
591Biotinylation of protein domains
Table 1 Oligonucleotides employed in the mutagenesis of the biotinyl
domain sub-gene
The oligonucleotide sequences encoding the biocytin motif are indicated in bold.
Mutant Oligonucleotide
MAK senMAK 5« GAAGCCATGGCAAAGATGAACCAGAT
antMAK 5« GTTCATCTTTGCCATGGCTTCAACGA
KAM senKAM 5« GAAGCCAAGGCAATGATGAACCAG
antKAM 5« GTTCATCATTGCCTTGGCTTCAACGA
DKA senDKA 5« GAAGCCGATAAAGCGATGAACCAG
antDKA 5« GTTCATCGCTTTATCGGCTTCAACGA
KKM senKKM 5« GTTGAAGCCAAGAAAATGATGAAC
antKKM 5« CATCATTTTCTTGGCTTCAACGA
MKK senMKK 5« GCCATGAAAAAGATGAACCAGAT
antMKK 5« CTGGTTCATCTTTTTCATGGCTTC
cloned into pGEX-2T, to express the biotinyl domain as a fusion
protein with glutathione S-transferase (GST). The resulting
plasmid (pGwtBCCP) was propagated in E. coli XL1-Blue cells,
and the DNA sequence encoding the entire biotinyl domain was
checked on both strands to verify its identity.
Directed mutagenesis of biotinyl domains by overlap extension
PCR
The mutant biotinyl domains MAK, KAM, MKK, KKM and
DKA were generated by overlap extension PCR [31]. For each
mutant, three PCR fragments were obtained: the upstream PCR
fragment, the downstream PCR fragment and the overlapping
PCR extension fragment. In addition, a pair of sense and anti-
sense oligonucleotides overlapping on their 3«-ends (20–25 bp)
were required for each mutant (Table 1). These oligonucleotides
primed in the region to be modified and encoded the appropriate
changes of amino acid residue (Table 1). Upstream PCR frag-
ments were obtained using the Dbccp oligonucleotide (described
above) and the anti-sense oligonucletides listed in Table 1 as
primers. Downstream PCR fragments were obtained using the
sense oligonucleotides (Table 1) and the Rbccp oligonucleotide
(described above) as primers. Downstream and upstream PCR
reactions were carried out using 25 ng of pGwtBCCP plasmid
DNA as template. Overlapping extension PCRs to generate the
entire mutated sub-genes were performed using 20 ng of the
appropriate purified downstream and upstream PCR fragments
as template, and the oligonucleotides Dbccp and Rbccp as
primers. The overlapping fragments were purified after agarose
gel electrophoresis, digested with BamHI and EcoRI, and then
cloned into pGEX-2T cut with the same enzymes. In this way
five plasmids were generated (pGkamBCCP, pGmakBCCP,
pGkkmBCCP, pGmkkBCCP and pGdkaBCCP), each encoding
a mutated biotinyl domain. The plasmids were propagated in
E. coli XL1-Blue cells and the DNA sequences of the sub-genes
were all verified.
Expression and purification of recombinant wild-type and mutant
biotinyl domains
E. coli BL21(DE3) cells transformed with the plasmids bearing
the wild-type and mutated sub-genes were grown in LB medium
[30] containing 100 lg}ml ampicillin and 10 mg}l d-biotin,
and the cells were induced at an A
'!!
of 0±7–0±8 with IPTG (final
concentration 1 mM). The cultures were grown for a further
3–6 h and harvested by centrifugation. The cells were washed in
PBS [30], resuspended in 10 ml of PBS containing 1 mM PMSF,
disrupted (131¬10' Pa) in a French press (SLM-AMINCO)
and the cell debris removed by centrifugation (15000 g for 1 h at
4 °C). Samples were then loaded on to a Pharmacia Glutathione
4B Sepharose2 affinity column (1±6 cm¬10 cm; flow rate 0±4
ml}min) equilibrated with PBS. The column was washed with the
same buffer until a stable base line (A
#)!
) was reached, and 100
units of thrombin (Calbiochem-Novabiochem Corporation) in
5 ml of PBS were then loaded on to the column (flow rate
1 ml}min). The column was incubated at 37 °C for 2 h and the
recombinant biotinyl domain released by thrombin cleavage was
then eluted from the column with PBS (100 ml) at a flow rate of
1 ml}min. Fractions (2 ml) containing the protein domain were
concentrated using Centriprep-3 concentrators (Amicon) and
loaded (in 2 ml batches) on to a Pharmacia SuperdexTM 30 HR
16}60 gel filtration column (flow rate 1 ml}min) previously
equilibrated with 20 mM potassium phosphate buffer, pH 7±0.
Fractions containing the protein domain were pooled, concen-
trated and stored at ®80 °C for future use.
Anion-exchange chromatography of wild-type and mutant biotinyl
domains
Further purification of the recombinant domains was carried out
by anion-exchange chromatography on a Pharmacia ResourceTM
Q HR 16}10 column. Protein domains were loaded on to the
column (flow rate 5 ml}min) previously equilibrated with 20 mM
potassium phosphate (buffer A), pH 7±5, for purification of the
wild-type biotinyl domain; pH 7±0 for the DKA mutant ; and
pH 8±0 for the KKM and MKK mutants. Biotinylated and
unbiotinylated forms of the recombinant domains were resolved
by applying a linear gradient (80 ml) of 0±1–0±2 M NaCl at a flow
rate of 5 ml}min. Fractions (1 ml) of interest were pooled,
dialysed against buffer A, pH 7±0, concentrated and stored at
®80 °C.
Expression and purification of BPL
BPL was purified from E. coli BL21(DE3)plysS cells transformed
with the plasmid pTbpl (P. Reche and R. N. Perham, un-
published work). pTbpl was derived from the plasmid pMBR10
[32] and carries the gene encoding the BPL of E. coli under the
T7lac promoter in pET11c. Cells were grown in LB medium
containing 100 lg}ml ampicillin and at an A
'!!
of 0±6–0±8
were induced with IPTG (final concentration 1 mM). Cells were
harvested by centrifugation and resuspended in 50 mM Tris}
HCl, pH 8±2, containing 100 mM KCl, 1 mM DTT, 0±1 mM
EDTA and 5% glycerol (buffer B). The cells were disrupted in a
French press and the cell-free extract was applied to a Pharmacia
HiloadTM Q HR 16}10 anion-exchange column (flow rate
2±5 ml}min). The recombinant protein was eluted with a linear
gradient (70 ml) of 0–1 M KCl in buffer B at a flow rate of
2±5 ml}min. Fractions (2±5 ml) containing the protein of interest
were pooled, concentrated (using a Centriprep-10 from Amicon)
and loaded on to a Pharmacia SuperdexTM 75 HR 16}60 filtration
column (flow rate 1 ml}min) equilibrated with 50 mM potassium
phosphate, pH 6±8, containing 100 mM KCl, 1 mM DTT,
0±1 mM EDTA and 5% glycerol (buffer C). Fractions (1 ml)
containing the recombinant BPL were pooled and applied to a
Pharmacia HiloadTM S HR 16}10 cation-exchange column (flow
rate 2±5 ml}min). BPL was eluted with a linear gradient (70 ml)
of 0–1±0 M of KCl in buffer C at a flow rate of 2±5 ml}min.
Fractions (1 ml) containing the recombinant enzymewere pooled,
dialysed against buffer C, concentrated and stored at ®80 °C.
592 P. Reche and others
Purification of LPL
E. coli BL21(DE3) cells transformed with the plasmid TM202
[24] were grown in LB medium containing 100 lg}ml ampicillin
and at an A
'!!
of 0±6–0±7 were induced with IPTG (final
concentration 1 mM) for a further 6 h. The cells were then
harvested by centrifugation and resuspended in 10 ml of 50 mM
Tris}HCl, pH 7±5, containing 1 mM PMSF, 1 mM EDTA and
10% glycerol (buffer D). The cells were harvested again by
centrifugation and disrupted in a French press. The cell-free
extract was applied to a Pharmacia HiloadTM Q HR 16}10
column (flow rate 2±5 ml}min), and the recombinant protein was
eluted by applying a linear gradient (100 ml) of NaCl (0–1 M) in
buffer A. Fractions (2±5 ml) containing the ligase were concen-
trated to 1 ml, using a PM10 membrane in an Amicon stirred
cell, and applied to a Pharmacia SuperdexTM 75 HR 16}60 gel
filtration column (flow rate 1 ml}min) equilibrated with buffer
D. Fractions of interest (1 ml) were pooled, concentrated and
stored at ®80 °C.
Expression and purification of E2p lipoyl domain
A recombinant lipoyl domain from E. coli E2p was purified using
the expression plasmid pET11cE2p (E. L. Roberts and R. N.
Perham, unpublished work). This plasmid is derived from the
plasmid pGS233 [33] and carries the sub-gene encoding the
innermost of the three lipoyl domains of E. coli E2p [34] under
the control of the T7lac promoter in pET11c. E. coli BL21(DE3)
cells transformed with pET11cE2p were grown in LB medium
containing 100 lg}ml ampicillin and at an A
'!!
of 0±7–0±8 were
induced for expression with IPTG (final concentration 1 mM)
for 2 h. Recombinant protein was then purified from the cell-free
extract by fractional precipitation with (NH
%
)
#
SO
%
(30–80%
saturation), followed by gel filtration on a Pharmacia SuperdexTM
75 column and ion-exchange chromatography on a Pharmacia
ResourceTM Q column, essentially as described elsewhere [28].
Lipoylation and biotinylation reactions in vitro
Biotinylation reactions were carried out in 15 ll mixtures con-
taining 50 mM Tris}HCl, pH 8±3, 4 mM MgCl
#
, 2±6 mM ATP
(pH 7±0), 200 lM d-biotin and approximately 3 lg of the sub-
strate protein. Lipoylation reactions were carried out in 15 ll
mixtures containing 30 mM potassium phosphate buffer, pH 7±5,
1±5 mM ATP (pH 7±0), 1±5 mM MgCl
#
and 200 lM lipoic acid
(pH 7±0) and approximately 3 lg of the substrate protein.
Reactions were started by the addition of the relevant ligase and
were incubated at 22–24 °C for 30 min, unless otherwise stated.
After incubation, reactions were subjected to non-denaturing
PAGE. The amounts of modified and unmodified domains were
determined densitometrically from scanned pictures of the rel-
evant gels using the program Phoretix 1D Advanced (v 3.0).
Determination of molecular mass
Molecular masses of recombinant domains were estimated by
electrospray (ES)-MS using a VG BioQ quadrapole mass spectro-
meter and myoglobin as the calibration standard. Proteins for
ES-MS were prepared in aqueous solution (salt concentration
! 2 mM) at a concentration of approx. 5 lM. Samples were
diluted in acetonitrile (50% final concentration) and formic acid
(1% final concentration). Theoretical molecular masses were
calculated from the amino acid sequences using the MW}pI
computing tool from the ExPasy Database.
General techniques for protein analysis and purification
Protein purifications were carried out on a Pharmacia FPLCTM
at 4 °C (unless otherwise stated) and column fractions were
analysed by SDS}PAGE (12±5 and 20% acrylamide) using the
Pharmacia PhastSystemTM. The concentrations of pure proteins
were estimated by amino acid analysis [35]. Biotinylated and
lipoylated forms of the domains were separated by means of non-
denaturing PAGE (20% acrylamide}1% bis-acrylamide as
separating gel ; 5% acrylamide as stacking gel) using a Tris}
glycine buffer [36] lacking SDS. All gels were stained with
Coomassie Brilliant Blue R-250.
RESULTS
Cloning, expression and purification of the wild-type BCCP biotinyl
domain
A plasmid, pGwtBCCP, was constructed that encodes a fusion
protein with GST at the N-terminus, followed by a thrombin
cleavage site and an 82-residue peptide corresponding to the
biotinyl domain of the BCCP component of E. coli ACC at the
C-terminus. As judged by means of SDS}PAGE and Coomassie
Blue staining (results not shown), the fusion protein represented
20–30% of the total soluble protein in E. coli BL21(DE3) cells
after IPTG induction. The biotinyl domain was purified by
means of glutathione–Sepharose2 affinity chromatography,
thrombin cleavage of the retained fusion protein, followed by
filtration of the released biotinyl domain on a SuperdexTM 30
column to remove contaminating material (see the Materials and
Methods section). The purified domain was found to be at least
98% pure, as judged from Coomassie-stained 20% SDS}PAGE
gels (results not shown). The average yield of domain was 3 mg}l
of E. coli cell culture. N-terminal sequence analysis revealed the
expected Gly-Ser sequence generated by the thrombin cleavage,
indicating a polypeptide chain of 84 residues in total.
Construction of the mutant biotinyl domains MAK, KAM, KKM,
MKK and DKA
The sub-gene encoding the biotinyl domain in pGwtBCCP was
subjected to site-directed mutagenesis (see the Materials and
Methods section) in the region encoding the highly conserved
MKM sequence motif (residues M49, K50 and M51) that
embodies the biotinyl-lysine residue (Figure 1). Mutant biotinyl
domains with the altered sequence motifs MAK, KAM, KKM,
MKK and DKA were generated. The KAM and MAK mutants
present the target lysine residue for biotinylation moved by one
position (to the N- and C-terminal side, respectively) in the b-
turn, whereas the MKK and KKM mutants offer two possible
target lysine residues in adjacent positions. In the DKA mutant,
the target lysine residue is situated in the conserved DKA motif
found in the structurally related lipoyl domains [13].
Post-translational modification of the wild-type and mutant
biotinyl domains in vivo
Wild-type and mutant biotinyl domains were purified from E.
coli BL21(DE3) cells after induction with IPTG in media
supplemented with 10 mg}l d-biotin (see the Materials and
Methods section). The purified domains were analysed by means
of non-denaturing 20% PAGE, where the biotinylated form of
the domain can be distinguished from the apo-form because it
carries one fewer positive charge and therefore migrates more
rapidly towards the anode (Figure 2). In addition, the proteins
were analysed by ES-MS. The molecular mass of the wild-type
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Figure 2 Post-translational modification of the wild-type and mutant
biotinyl domains in vivo
Sub-genes encoding the protein domains were expressed after induction with IPTG of E. coli
Bl21(DE3) cells transformed with the relevant plasmids and grown in the presence of 10 mg/l
d-biotin. Approximately 3 lg of each of the purified domains was subjected to non-denaturing
PAGE (20% gels) and stained with Coomassie Blue. (a) Lane 1, wild-type biotinyl domain
(MKM) ; lane 2, MAK mutant ; lane 3, KAM mutant ; lane 4, DKA mutant ; lane 5, KKM mutant ;
lane 6, MKK mutant. The domains were purified from cells 3 h after induction. (b) DKA mutant
domain purified from E. coli cells 6 h after induction and growth in the presence of : lane 1,
10 mg/l d-biotin ; lane 2, 10 mg/l DL-lipoic acid ; lane 3, 10 mg/l octanoic acid. In each lane,
the upper band represents the apo-form of the domain. Abbreviations : lip, lipoyl ; oct, octanoyl.
biotinyl domain was found to be 9204³0±5 Da, 226 Da more
than that calculated from the amino acid sequence (8978 Da)
and corresponding exactly to that required for the addition of a
biotinyl group [37]. The extent of biotinylation of the wild-type
domain was over 90%, as judged by non-denaturing PAGE
(Figure 2a). Thus the wild-type biotinyl domain appears to be
almost fully biotinylated in io under the conditions used. The
molecular mass of the putative apo-form was also determined by
means of ES-MS after it was separated from the modified form
by means of anion-exchange chromatography and, as expected,
its molecular mass (8978³0±8 Da) was that calculated from the
amino acid sequence.
The MAK and KAM mutant domains, when subjected to
non-denaturing PAGE, displayed a single protein band (Figure
2a). Their measured molecular masses (MAK 8918³0±6 Da,
KAM 8918³0±7 Da) corresponded exactly with those of the
apo-forms, as calculated from the amino acid sequences
(8918 Da), which indicates that they were not biotinylated in
io. In contrast, the KKM mutant displayed two protein bands
of approximately the same intensity in non-denaturing PAGE
(Figure 2a). It also revealed two components on ES-MS, whose
molecular masses were those expected for the apo-protein
(measured mass 8975³2 Da, expected mass 8975 Da) and the
singly biotinylated form of the domain (measured mass
9202³1 Da, expected mass 9201 Da). Thus, under the exper-
imental conditions used (E. coli cells were harvested 3 h after
induction in a medium supplemented with biotin), 50% of the
mutant was biotinylated in io. We could not detect any doubly
biotinylated form of the KKM mutant by means of non-
denaturing PAGE or ES-MS. Likewise, post-translational modi-
fication of the MKK mutant was found to occur in io, but to
be less efficient than that of the KKM mutant. In non-denaturing
PAGE (Figure 2a) the protein band corresponding to the
modified form represented only 10% of the total domain and its
Figure 3 ES mass spectrum of the DKA mutant biotinyl domain
The post-translationally modified form of the DKA mutant domain (faster-migrating protein band
in non-denaturing PAGE) was purified and analysed by ES-MS. A-series of peaks, octanoylated
DKA domain, mass 9030³2 Da (predicted mass 9028 Da) ; B-series, lipoylated DKA domain,
mass 9090³1 Da (predicted mass 9090 Da). The integers by each peak indicate the number
of positive charges borne by the species.
Figure 4 Biotinylation of the biotinyl domains with BPL in vitro
Samples (approx. 22 lM) of purified apo-biotinyl domain were incubated for 30 min with BPL
under the conditions described in the Materials and methods section and then analysed by
means of non-denaturing PAGE (20% gels). The gels were stained with Coomassie Blue. (a)
The mutant domains were incubated with BPL (concentration 0±7 lM) ; MAK mutant without
BPL (lane 1) and with BPL (lane 2) ; KAM mutant without BPL (lane 3) and with BPL (lane 4) ;
DKA mutant reaction mixtures without BPL (lane 5) and with BPL (lane 6) ; KKM mutant without
BPL (lane 7) and with BPL (lane 8) ; MKK mutant without BPL (lane 9) and with BPL (lane 10).
(b) Wild-type (MKM) domain incubated without BPL (lane 1) and with 0±2 lM BPL (lane 2) ;
KKM mutant incubated without BPL (lane 3), with 0±5 lM BPL (lane 4), with 0±6 lM BPL
(lane 5), and with 0±7 lM BPL (lane 6) ; MKK mutant incubated without BPL (lane 7), with
1±4 lM BPL (lane 8), with 2±8 lM BPL (lane 9) and with 5±6 lM BPL (lane 10). In each lane,
the symbol ­ or ® represents incubation with or without BPL respectively. Abbreviation : bio,
biotinyl.
molecular mass (9201³1 Da), as determined by ES-MS, corre-
sponded with that of the singly biotinylated form of the protein
(9201 Da). Again, no doubly biotinylated form was detected.
The purified DKA mutant domain also contained two com-
ponents when subjected to non-denaturing PAGE (Figure 2a),
that corresponding to the apo-domain (upper band) representing
90% of the protein. These two components were purified and
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Figure 5 Lipoylation of the DKA mutant biotinyl domain by LPL in vitro
Samples (approx. 3 lg) of purified apo-DKA mutant domain were incubated with LPL under the
conditions described in the Materials and Methods section and then analysed by means of non-
denaturing PAGE (20% gels). The gels were stained with Coomassie Blue. (a) All incubations
were for 30 min. Control samples of the innermost of the three lipoyl domains from E. coli E2p
were incubated without LPL (lane 1) and with 1±8 lM LPL (lane 2). The DKA biotinyl domain
was incubated without LPL (lane 3), with 1±8 lM LPL (lane 4), with 3±6 lM LPL (lane 5), with
7±2 lM LPL (lane 6), with 18 lM LPL (lane 7) and with 36 lM LPL (lane 8). (b) Same as
(a), except the incubations were extended to 12 h. (c) Protein domains were incubated for
30 min with LPL at a concentration of 18 lM. The wild-type biotinyl domain was incubated
without LPL (lane 1) and with LPL (lane 2) ; the DKA mutant was incubated without LPL (lane
3) and with LPL (lane 4). In each lane, the symbol ­ or ® represents incubation with or
without LPL respectively. Abbreviations : lip, lipoyl ; WT, wild-type.
analysed by ES-MS. The molecular mass of the upper protein
band (8902³1 Da) was that expected for the apo-form of the
mutant (8902 Da). The mass spectrum of the lower protein band
(Figure 3) displayed two products, with molecular masses of
9090 Da and 9030 Da. These mass differences correspond closely
with those predicted if the protein had been lipoylated (­188 Da)
and octanoylated (­126 Da) respectively. The molar ratio be-
tween the putative lipoylated and octanoylated forms of the
DKA mutant was approximately 1:1 and no biotinylated form
of the domain was detectable. The ratio ofmodified to unmodified
form of the DKA mutant did not change significantly when the
expression of the relevant mutant was induced in the presence of
lipoic acid or octanoic acid instead of d-biotin (Figure 2b), nor
did the proportion of lipoylated to octanoylated form, as judged
by ES-MS, under the same conditions (results not shown). How-
ever, increasing the time of expression from 3 h (Figure 2a) to 6 h
(Figure 2b) was accompanied by an increase of the modified
protein band from approx. 10% to 20%.
Biotinylation of the biotinyl domains in vitro
Biotinylation of the apo-biotinyl domains was carried out in itro
by incubating them with purified BPL under the conditions
described in the Materials and Methods section. The extent of
biotinylation was analysed by means of non-denaturing PAGE
(Figure 4a) and the results were found to be fully consistent with
those obtained in io. Thus, the MAK or KAM mutants were
not biotinylated; the KKM and MKK mutants were biotinylated
but neither of them appeared to be doubly biotinylated; and the
DKA mutant was not biotinylated at all (even if the incubation
time was extended to 12 h or more). The concentration of BPL
used in these experiments was 0±7 lM, which in preliminary
experiments had been found to be sufficient to achieve the
complete biotinylation of the wild-type biotinyl domain in 5 min
(data not shown). We also studied the biotinylation of the KKM
and MKK mutant domains by varying the concentration of BPL
in the reaction mixture. Under identical conditions the con-
centration of ligase needed to biotinylate the KKM and MKK
mutants was found to be 2- and 20-fold respectively that required
to achieve complete modification of the wild-type biotinyl domain
(Figure 4b).
Lipoylation of the biotinyl domains in vitro
In view of the lipoylation and octanoylation of the DKA biotinyl
domain observed in io, we attempted to lipoylate the domain
in itro using the LPL. The concentration of LPL was varied
under the conditions described in the Materials and Methods
section and the reaction mixtures were analysed by means of
non-denaturing PAGE. The DKA mutant was observed not to
be lipoylated in 30 min at concentrations of LPL up to 1±8 lM
(Figure 5a), nor did it become detectably lipoylated if the
incubation timewas increased to 12 h (Figure 5b).Under identical
conditions, the lipoyl domain of E. coli E2p was fully lipoylated
in less than 5 min (Figure 5). However, when the concentration
of LPL was increased 10-fold or more, lipoylation of the DKA
biotinyl domain was significant (Figure 5, lanes 7 and 8), but an
incubation of more than 12 h was required to bring it to
completion (results not shown). This large amount of LPL was
also found to be capable of catalysing the lipoylation of the wild-
type biotinyl domain to a similar extent (Figure 5c). In all cases
the identities of the products were verified by ES-MS.
DISCUSSION
The biotin cofactor of E. coli acetyl-CoA carboxylase is attached
covalently by amide linkage to the N '-amino group of a unique
lysine residue of the BCCP component. The attachment is
catalysed by BPL as a post-translational modification, and the
ligase selects a unique target lysine residue located in a conserved
amino acid sequence motif MKM near the tip of a tight b-turn
in the structure of the biotinyl domain (Figure 1). Li and Cronan
[3] were the first to show that fusion of the C-terminal 84 amino
acids of BCCP to b-galactosidase led to the production of
biotinylated b-galactosidase molecules in io. However, the
expression level of this fusion protein was low. Chapman-Smith
et al. [5] have also reported the expression of a sub-gene in E. coli
encoding the C-terminal 87 residues of the E. coli BCCP,
generating a partly biotinylated protein in io. As pointed out
by these authors, the production of the peptide, where expression
was under the control of the T7 promoter of pET, appeared to
have saturated the capacity of the intracellular BPL. The
GST–biotinyl domain fusion that we have used allows the
preparation of a biotinyl domain that has been biotinylated to a
large extent (90% or more) in io under the conditions used
(supplementing the growth medium with 10 mg}l d-biotin). A
small amount of apo-domain (Figure 2) could be separated from
the biotinylated form by ion-exchange chromatography.
The presentation of the target lysine residue in the structure of
the biotinyl domain is evidently of crucial importance for the
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biotinylation reaction. Thus, the KAM and MAK mutant
domains, with the lysine residue moved one position to the N-
and C-terminal side respectively, were not biotinylated either in
io (Figure 2) or in itro (Figure 4) and the KKM or MKK
mutant domains, with two potential sites for biotinylation, were
found to be biotinylated at only one site. Given the results with
the KAM and MAK mutants, it is reasonable to suppose that
this is the lysine residue in its normal position, though this has
not been formally proved by amino acid sequence analysis. Thus,
as with lipoylation of the lipoyl domain from 2-oxo acid
dehydrogenase multienzyme complexes where a full sequence
analysis was carried out [29], it clearly is essential for the target
lysine residue to be properly positioned in the hairpin loop on the
surface of the biotinyl domain for post-translational modification
to occur.
However, the biotinylation of the KKM and MKK mutant
domains, although it occurred, was significantly impaired. Under
identical conditions in io, the modification of the KKM mutant
reached 50% of that of the wild-type domain and that of the
MKK mutant only 10%. The DKA mutant domain was not
biotinylated at all. Similar results were obtained when the
biotinylation of the various domains by purified BPL was
examined in itro (Figure 4). Thus it would appear that the
methionine residues flanking the target lysine form part of the
surface of the biotinyl domain that is recognized by BPL. None
the less, although the MKM motif for the biotinylated lysine
residue is highly conserved in all biotinylated proteins [8], it is not
sufficient to ensure biotinylation. This is clear from the ob-
servation that importing the MKM motif into the lipoyl domain
of Bacillus stearothermophilus pyruvate dehydrogenase complex
leaves it capable of being lipoylated but does not render it a
substrate for biotinylation in io in E. coli [29].
Replacement of the methionine residues flanking the target
lysine with leucine on the biotinyl domain of the a-subunit from
human propionyl-CoA carboxylase [38] and the 1±3 S subunit of
Pseudomonas shermanii transcarboxylase [39] has demonstrated
that the methionine residues are not essential for correct bio-
tinylation of these proteins in io by E. coli BPL. However, in
the P. shermanii transcarboxylase, further analysis showed the
subsequent carboxylation of the biotin moiety to be defective
[40]. Taking these data together with our own results, it appears
that methionine residues flanking the target lysine residue may
have been evolutionarily selected in order to be compatible with
the interaction first with the BPL and subsequently with the
relevant carboxylase. Further investigation of the effects of
systematic exchange of the methionine residues on the bio-
tinylation and carboxylation reactions will be necessary to
understand these protein–protein interactions and their needs
for compatibility in more detail.
Previous studies of the lipoylation of the lipoyl domain from
the pyruvate dehydrogenase multienzyme complex of B. stearo-
thermophilus in E. coli indicated that the conserved aspartic acid
and alanine residues surrounding the target lysine residue (the
DKA motif) are not essential for lipoylation, but that the correct
positioning of the lysine at the tip of the tight b-turn in the
domain is crucial [29]. The DKA motif is replaced by DKV in the
lipoyl domains of the 2-oxoglutarate dehydrogenase complexes
of E. coli [15,41] and Azobacter inelandii [16], by AKA in the
N-terminal lipoyl domain of the pyruvate dehydrogenase com-
plex of A. inelandii [17], and by VKA in the lipoylated H-protein
of the glycine decarboxylase complex of ox [42], pea leaf [43,44]
and E. coli [45]. None the less, all these domains can be lipoylated
in io in E. coli. Thus, we were surprised to find that the DKA
mutant biotinyl domain was lipoylated and octanoylated in io,
albeit at a low level (Figures 2 and 3). Octanoylation of lipoyl
domains as an aberrant modification in io, under conditions of
lipoic acid deficiency [27] or where over-expression of the lipoyl
domain swamps the lipoylating machinery of the E. coli cell, has
been observed before [28,42].
It would appear that the DKA motif, when displayed at the
right position in a structurally related protein, is sufficient to
direct lipoylation of the target lysine residue in io. This is in
contrast with the lack of lipoylation of the lipoyl domain of the
bovine branched-chain 2-oxo acid dehydrogenase complex,
which also exhibits the DKA motif, expressed in E. coli [46]. It
is significant that the lipoylation of the DKA biotinyl domain
catalysed by the purified E. coli LPL in itro, although it took
place, was very slow. Indeed, it was not very different from the
lipoylation of the wild-type biotinyl domain under forcing
conditions (stoichiometric amounts of domain and ligase) in itro
(Figure 5). This may indicate that the post-translational modi-
fication of the DKA mutant domain in io is catalysed by an
enzyme different from the purified LPL used here, the product of
the lplA gene [24]. That enzyme could be the lipB-dependent
LPL, which is believed to be responsible for most of the
octanoylation occurring in io [23]. However, it cannot be
discounted that the lipoylation of the DKA mutant observed in
io could also be due, at least in part, to the product of the lplA
gene under the conditions of high level expression of the domain.
Overall, it is apparent that lipoylation and biotinylation of the
relevant protein domains do not rely simply on the recognition
of unique and well-conserved sequence motifs. Instead, the
recognition process between the domain and its cognate ligase
has a major structural component to it, notably the positioning
of the target lysine residue in the exposed hairpin loop in one of
the two b-sheets that make up the domains, together with
additional recognition sites elsewhere on the domains. This
emerging position has been somewhat clouded recently by the
observation that a 13-residue peptide tag can be added to
proteins that appears to target biotinylation by BPL to a lysine
residue embedded in it [47,48]. Whether this peptide has any
persistent structure in solution, and if so whether it resembles the
b-turn that houses the biotinylated lysine residue in native
proteins, is unknown. How these recognition processes function
at the molecular level remains an important problem to be solved
in detail.
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